Hudson Bay Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.96M	Sell	70,780 -129,220	-65%	-$3.58M	0.01%	555
2025 Q1	$4.44M	Sell	200,000 -25,000	-11%	-$555K	0.01%	371
2024 Q4	$4.45M	Buy	225,000 +135,000	+150%	+$2.67M	0.02%	378
2024 Q3	$2.25M	Sell	90,000 -165,000	-65%	-$4.12M	0.01%	414
2024 Q2	$4.76M	Buy	255,000 +104,000	+69%	+$1.94M	0.02%	308
2024 Q1	$2.98M	Sell	151,000 -64,000	-30%	-$1.26M	0.02%	335
2023 Q4	$3.77M	Sell	215,000 -87,500	-29%	-$1.53M	0.02%	295
2023 Q3	$5.25M	Sell	302,500 -377,500	-56%	-$6.56M	0.04%	233
2023 Q2	$9.57M	Sell	680,000 -180,200	-21%	-$2.54M	0.07%	146
2023 Q1	$9.26M	Buy	860,200 +260,200	+43%	+$2.8M	0.08%	150
2022 Q4	$8.99M	Sell	600,000 -600,000	-50%	-$8.99M	0.09%	183
2022 Q3	$15.4M	Sell	1,200,000 -175,000	-13%	-$2.25M	0.14%	80
2022 Q2	$13.3M	Buy	1,375,000 +95,000	+7%	+$921K	0.1%	108
2022 Q1	$12.7M	Buy	1,280,000 +230,000	+22%	+$2.29M	0.17%	88
2021 Q4	$12.4M	Sell	1,050,000 -100,000	-9%	-$1.18M	0.13%	89
2021 Q3	$13.1M	Buy	1,150,000 +350,000	+44%	+$3.99M	0.18%	81
2021 Q2	$11.1M	Buy	800,000 +305,000	+62%	+$4.25M	0.13%	100
2021 Q1	$9.16M	Sell	495,000 -105,000	-18%	-$1.94M	0.11%	129
2020 Q4	$10.6M	Buy	600,000 +150,000	+33%	+$2.65M	0.11%	106
2020 Q3	$6.89M	Buy	450,000 +265,000	+143%	+$4.06M	0.1%	170
2020 Q2	$4.71M	Sell	185,000 -45,000	-20%	-$1.15M	0.08%	195
2020 Q1	$3.56M	Sell	230,000 -210,000	-48%	-$3.25M	0.09%	191
2019 Q4	$4.87M	Buy	440,000 +310,000	+238%	+$3.43M	0.11%	166
2019 Q3	$1.11M	Buy	130,000 +15,000	+13%	+$128K	0.03%	283
2019 Q2	$1.56M	Buy	115,000 +25,000	+28%	+$338K	0.04%	265
2019 Q1	$1.63M	Buy	+90,000	New	+$1.63M	0.02%	293